The Use of Interferon-α in Virus Infections (Q36711548)

15 August 2017

1 reference

title

The use of interferon-alpha in virus infections (English)

1 reference

15 August 2017

The Use of Interferon-α in Virus Infections (English)

1 reference

10.2165/00003495-199142050-00003

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199142050-00003

9 November 2022

7

N. Sheron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

author name string

Scott G

8

1 reference

15 August 2017

Phua S

9

1 reference

15 August 2017

Tatum PB

10

1 reference

15 August 2017

N. B. Finter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

S. Chapman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

P. Dowd

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

J. M. Johnston

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

V. Manna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

N. Sarantis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

N. Sheron

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

G. Scott

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

S. Phua

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

P. B. Tatum

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1723372

9 November 2022

publication date

1 November 1991

1 reference

full work available at URL

15 August 2017

https://europepmc.org/articles/PMC7100942

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

https://europepmc.org/articles/PMC7100942?pdf=render

9 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1723372

9 November 2022

1 reference

15 August 2017

42

1 reference

15 August 2017

5

1 reference

15 August 2017

749-765

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199142050-00003

15 August 2017

0 references

cites work

Interferon for the therapy of condyloma acuminatum.

1 reference

12 December 2020

Dane particle DNA polymerase and HBeAg: Impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver disease

1 reference

12 December 2020

Interferon therapy for condylomata acuminata

1 reference

12 December 2020

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

12 December 2020

Purification and characterization of a human Mx protein

1 reference

12 December 2020

Psychiatric complications of long-term interferon alfa therapy.

1 reference

12 December 2020

Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials

1 reference

12 December 2020

Interferon and laryngeal papillomatosis. The Iowa experience

1 reference

12 December 2020

Human Tolerance and Histopathologic Effects of Long-Term Administration of Intranasal Interferon- 2

1 reference

12 December 2020

Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system

1 reference

12 December 2020

Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

1 reference

12 December 2020

Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial

1 reference

12 December 2020

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Treatment of common and plantar viral warts with human lymphoblastoid interferon-alpha--pilot studies with intralesional, intramuscular and dermojet injections

1 reference

12 December 2020

Interference phenomena between animal viruses; a review.

1 reference

12 December 2020

The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK.

1 reference

12 December 2020

Human leukocyte interferon produced by E. coli is biologically active

1 reference

12 December 2020

The effect of interferon on cells persistently infected with HIV.

1 reference

12 December 2020

Hepatitis B virus (HBV)--the challenges ahead

1 reference

12 December 2020

Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines

1 reference

12 December 2020

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

12 December 2020

Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro

1 reference

12 December 2020

Virus interference. I. The interferon

1 reference

12 December 2020

Intranasal Lymphoblastoid Interferon ("Well fer on") Prophylaxis Against Rhinovirus and Influenza Virus in Volunteers

1 reference

12 December 2020

Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis

1 reference

12 December 2020

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

12 December 2020

Leucocyte-derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b

1 reference

12 December 2020

Administration of human fibroblast interferon in chronic hepatitis-B infection

1 reference

12 December 2020

Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease

1 reference

12 December 2020

Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds

1 reference

12 December 2020

Long-term follow-up of serum-interferon and its acid-stability in a group of homosexual men

1 reference

12 December 2020

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of injections of small doses of human fibroblast interferon into genital warts. A pilot study

1 reference

12 December 2020

Detection and incidence of neutralizing antibodies to interferon-alpha-n1

1 reference

12 December 2020

Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations

1 reference

12 December 2020

Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose

1 reference

12 December 2020

Treatment of verrucae vulgaris with alpha 2 interferon

1 reference

12 December 2020

Lymphoblastoid interferon therapy of chronic HBV infection

1 reference

12 December 2020

Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

12 December 2020

Tolerance of one-month intranasal interferon

1 reference

12 December 2020

Leukocyte interferon in patients with juvenile laryngeal papillomatosis

1 reference

12 December 2020

Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers

1 reference

12 December 2020

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial

1 reference

12 December 2020

An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-α2

1 reference

12 December 2020

Some highlights of virus research in 1988.

1 reference

12 December 2020

Purified interferon as protection against rhinovirus infection

1 reference

12 December 2020

Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions

1 reference

12 December 2020

Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum

1 reference

12 December 2020

Sexually transmitted diseases: extract from the annual report of the Chief Medical Officer of the Department of Health and Social Security for the year 1983

1 reference

12 December 2020

Systemic interferon alpha-2b increases the cure rate in laser treated patients with multiple persistent genital warts: a placebo-controlled study

1 reference

12 December 2020

Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.

1 reference

12 December 2020

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

1 reference

12 December 2020

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

1 reference

12 December 2020

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

12 December 2020

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

1 reference

12 December 2020

Recombinant human interferon-beta suppresses the replication of HIV and acts synergistically with AZT

1 reference

12 December 2020

Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

1 reference

12 December 2020

Interferon antibodies may negate the antiviral effects of recombinant alpha-interferon treatment in patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Human nasal mucosal responses to topically applied recombinant leukocyte A interferon

1 reference

12 December 2020

A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

12 December 2020

Natural interferon alfa for treatment of condylomata acuminata

1 reference

12 December 2020

Condyloma acuminatum in Rochester, Minn., 1950-1978. I. Epidemiology and clinical features

1 reference

12 December 2020

Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata

1 reference

12 December 2020

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

12 December 2020

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

12 December 2020

Optimum treatment of genital warts

1 reference

12 December 2020

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of chronic type B hepatitis in Southeast Asia

1 reference

12 December 2020

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

12 December 2020

Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris

1 reference

12 December 2020

Intralesional human lymphoblastoid interferon alpha for the treatment of cutaneous, nongenital viral warts

1 reference

12 December 2020

Treatment of AIDS-associated Kaposi's sarcoma with recombinant alpha interferon

1 reference

12 December 2020

Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy

1 reference

12 December 2020

Synthesis in E. coli of a polypeptide with human leukocyte interferon activity

1 reference

12 December 2020

Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis.

1 reference

12 December 2020

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

1 reference

12 December 2020

Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers

1 reference

12 December 2020

Suppression of p24 antigen in sera from HIV-infected individuals with low-dose alpha-interferon and zidovudine: a pilot study

1 reference

12 December 2020

The treatment of viral warts with interferons

1 reference

12 December 2020

Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children

1 reference

12 December 2020

Host gene influences sensitivity to interferon action selectively for influenza virus

1 reference

12 December 2020

A randomized placebo-controlled trial of recombinant human interferon alpha 2a in patients with AIDS. Interferon Alpha Study Group

1 reference

12 December 2020

Recombinant human interferon-gamma as prophylaxis against rhinovirus colds in volunteers

1 reference

12 December 2020

Interferon Therapy in Juvenile Laryngeal Papillomatosis

1 reference

12 December 2020

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

1 reference

12 December 2020

Distribution and removal of human serum albumin-technetium 99m instilled intranasally

1 reference

12 December 2020

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

1 reference

12 December 2020

Interferons and their actions

1 reference

12 December 2020

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

12 December 2020

Effect of intravenous recombinant gamma-interferon on the respiratory burst of blood monocytes from patients with AIDS

1 reference

12 December 2020

Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection

1 reference

12 December 2020

Inhibition of growth of HIV by human natural interferon in vitro.

1 reference

12 December 2020

Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon

1 reference

12 December 2020

Recombinant human interferon (IFN) alpha-2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti-interferon antibodies

1 reference

12 December 2020

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

12 December 2020

Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia

1 reference

12 December 2020

Intralesional human fibroblast interferon in common warts

1 reference

12 December 2020

Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A)

1 reference

12 December 2020

Recurrent condylomata acuminata treated with recombinant interferon alfa-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group

1 reference

12 December 2020

Long-term follow-up of 60 patients with chronic hepatitis B. I. Seroconversion in the hepatitis B e-system, frequency of delta infection and histological outcome.

1 reference

12 December 2020

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

1 reference

12 December 2020

Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers

1 reference

12 December 2020

Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.

1 reference

12 December 2020

Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro

1 reference

12 December 2020

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

1 reference

12 December 2020

Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections

1 reference

12 December 2020

Intralesional administration of large doses of human leukocyte interferon for the treatment of condylomata acuminata

1 reference

12 December 2020

Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.

1 reference

12 December 2020

Absence of interferon in lungs fom fatal cases of influenza

1 reference

12 December 2020

Production of interferon by human leukocytes in vitro

1 reference

12 December 2020

10.2165/00003495-199142050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

0 references

0 references

1 reference